Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $3.00 billion. The enterprise value is $2.45 billion.
| Market Cap | 3.00B |
| Enterprise Value | 2.45B |
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 61.38 million shares outstanding. The number of shares has increased by 14.65% in one year.
| Current Share Class | 61.38M |
| Shares Outstanding | 61.38M |
| Shares Change (YoY) | +14.65% |
| Shares Change (QoQ) | +7.51% |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 86.70% |
| Float | 49.27M |
Valuation Ratios
The trailing PE ratio is 11.56.
| PE Ratio | 11.56 |
| Forward PE | n/a |
| PS Ratio | 6.93 |
| Forward PS | 32.50 |
| PB Ratio | 4.42 |
| P/TBV Ratio | 4.44 |
| P/FCF Ratio | 16.41 |
| P/OCF Ratio | 16.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.67, with an EV/FCF ratio of 13.41.
| EV / Earnings | 8.91 |
| EV / Sales | 5.64 |
| EV / EBITDA | 9.67 |
| EV / EBIT | 9.70 |
| EV / FCF | 13.41 |
Financial Position
The company has a current ratio of 12.48, with a Debt / Equity ratio of 0.02.
| Current Ratio | 12.48 |
| Quick Ratio | 12.39 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.06 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 54.39% and return on invested capital (ROIC) is 30.87%.
| Return on Equity (ROE) | 54.39% |
| Return on Assets (ROA) | 28.66% |
| Return on Invested Capital (ROIC) | 30.87% |
| Return on Capital Employed (ROCE) | 36.26% |
| Revenue Per Employee | $3.45M |
| Profits Per Employee | $2.18M |
| Employee Count | 126 |
| Asset Turnover | 0.79 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $4.22 million in taxes.
| Income Tax | 4.22M |
| Effective Tax Rate | 1.51% |
Stock Price Statistics
The stock price has increased by +71.63% in the last 52 weeks. The beta is 2.33, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 2.33 |
| 52-Week Price Change | +71.63% |
| 50-Day Moving Average | 42.50 |
| 200-Day Moving Average | 41.34 |
| Relative Strength Index (RSI) | 53.01 |
| Average Volume (20 Days) | 1,659,882 |
Short Selling Information
The latest short interest is 5.13 million, so 8.36% of the outstanding shares have been sold short.
| Short Interest | 5.13M |
| Short Previous Month | 4.87M |
| Short % of Shares Out | 8.36% |
| Short % of Float | 10.41% |
| Short Ratio (days to cover) | 3.53 |
Income Statement
In the last 12 months, PTGX had revenue of $434.43 million and earned $275.19 million in profits. Earnings per share was $4.23.
| Revenue | 434.43M |
| Gross Profit | 434.43M |
| Operating Income | 252.84M |
| Pretax Income | 172.60M |
| Net Income | 275.19M |
| EBITDA | 253.67M |
| EBIT | 252.84M |
| Earnings Per Share (EPS) | $4.23 |
Balance Sheet
The company has $418.91 million in cash and $10.87 million in debt, giving a net cash position of $548.30 million or $8.93 per share.
| Cash & Cash Equivalents | 418.91M |
| Total Debt | 10.87M |
| Net Cash | 548.30M |
| Net Cash Per Share | $8.93 |
| Equity (Book Value) | 675.30M |
| Book Value Per Share | 11.06 |
| Working Capital | 544.24M |
Cash Flow
In the last 12 months, operating cash flow was $184.15 million and capital expenditures -$1.36 million, giving a free cash flow of $182.80 million.
| Operating Cash Flow | 184.15M |
| Capital Expenditures | -1.36M |
| Free Cash Flow | 182.80M |
| FCF Per Share | $2.98 |
Margins
Gross margin is 100.00%, with operating and profit margins of 58.20% and 63.34%.
| Gross Margin | 100.00% |
| Operating Margin | 58.20% |
| Pretax Margin | 64.32% |
| Profit Margin | 63.34% |
| EBITDA Margin | 58.39% |
| EBIT Margin | 58.20% |
| FCF Margin | 42.08% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.65% |
| Shareholder Yield | n/a |
| Earnings Yield | 9.17% |
| FCF Yield | 6.09% |
Analyst Forecast
The average price target for PTGX is $66.50, which is 36.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $66.50 |
| Price Target Difference | 36.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 1.54% |
| EPS Growth Forecast (5Y) | -2.05% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 19.83 and a Piotroski F-Score of 4.
| Altman Z-Score | 19.83 |
| Piotroski F-Score | 4 |